Literature DB >> 15590923

Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area.

Arthur C Riegel1, Carl R Lupica.   

Abstract

Dopamine (DA) neurons in the ventral tegmental area have been implicated in psychiatric disorders and drug abuse. Understanding the mechanisms through which their activity is regulated via the modulation of afferent input is imperative to understanding their roles in these conditions. Here we demonstrate that endocannabinoids liberated from DA neurons activate cannabinoid CB1 receptors located on glutamatergic axons and on GABAergic terminals targeting GABA(B) receptors located on these cells. Endocannabinoid release was initiated by inhibiting either presynaptic type-III metabotropic glutamate receptors or postsynaptic calcium-activated potassium channels, two conditions that also promote enhanced DA neuron excitability and bursting. Thus, activity-dependent release of endocannabinoids may act as a regulatory feedback mechanism to inhibit synaptic inputs in response to DA neuron bursting, thereby regulating firing patterns that may fine-tune DA release from afferent terminals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15590923      PMCID: PMC4857882          DOI: 10.1523/JNEUROSCI.3695-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  Brain reward circuitry: insights from unsensed incentives.

Authors:  Roy A Wise
Journal:  Neuron       Date:  2002-10-10       Impact factor: 17.173

2.  Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity.

Authors:  I D Smith; A A Grace
Journal:  Synapse       Date:  1992-12       Impact factor: 2.562

3.  Cannabinoid CB(1) receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme.

Authors:  M Hernández; F Berrendero; I Suárez; L García-Gil; M Cebeira; K Mackie; J A Ramos; J Fernández-Ruiz
Journal:  Brain Res       Date:  2000-02-28       Impact factor: 3.252

4.  GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area.

Authors:  P W Kalivas; L Churchill; M A Klitenick
Journal:  Neuroscience       Date:  1993-12       Impact factor: 3.590

5.  Membrane properties of rat locus coeruleus neurones.

Authors:  J T Williams; R A North; S A Shefner; S Nishi; T M Egan
Journal:  Neuroscience       Date:  1984-09       Impact factor: 3.590

6.  Biochemical evidence for gamma-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat.

Authors:  I Walaas; F Fonnum
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

7.  Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry.

Authors:  A Charara; Y Smith; A Parent
Journal:  J Comp Neurol       Date:  1996-01-08       Impact factor: 3.215

8.  Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum.

Authors:  J F Cheer; D A Kendall; R Mason; C A Marsden
Journal:  Neuropharmacology       Date:  2003-04       Impact factor: 5.250

9.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

Review 10.  Predictive reward signal of dopamine neurons.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1998-07       Impact factor: 2.714

View more
  93 in total

1.  Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.

Authors:  Cameron H Good; Carl R Lupica
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

Authors:  Megan L Fitzgerald; Eli Shobin; Virginia M Pickel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-11       Impact factor: 5.067

3.  Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization.

Authors:  D A Kupferschmidt; P G Klas; S Erb
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 4.  Endocannabinoid signalling in reward and addiction.

Authors:  Loren H Parsons; Yasmin L Hurd
Journal:  Nat Rev Neurosci       Date:  2015-09-16       Impact factor: 34.870

5.  Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood.

Authors:  Lauren C Kruse; Jessica K Cao; Katie Viray; Nephi Stella; Jeremy J Clark
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

Review 6.  Dopaminergic neurones: much more than dopamine?

Authors:  Vincent Seutin
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 7.  Endocannabinoid-dependent regulation of feedforward inhibition in cerebellar Purkinje cells.

Authors:  Cameron H Good
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

8.  Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.

Authors:  Stephanie C Gantz; Bruce P Bean
Journal:  Neuron       Date:  2017-03-02       Impact factor: 17.173

9.  Song-associated reward correlates with endocannabinoid-related gene expression in male European starlings (Sturnus vulgaris).

Authors:  Allison H Hahn; Devin P Merullo; Jeremy A Spool; Caroline S Angyal; Sharon A Stevenson; Lauren V Riters
Journal:  Neuroscience       Date:  2017-01-29       Impact factor: 3.590

10.  Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens.

Authors:  Yolanda Mateo; Kari A Johnson; Dan P Covey; Brady K Atwood; Hui-Ling Wang; Shiliang Zhang; Iness Gildish; Roger Cachope; Luigi Bellocchio; Manuel Guzmán; Marisela Morales; Joseph F Cheer; David M Lovinger
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.